about
R3F, a novel membrane-associated glycogen targeting subunit of protein phosphatase 1 regulates glycogen synthase in astrocytoma cells in response to glucose and extracellular signalsConditional independence mapping of DIGE data reveals PDIA3 protein species as key nodes associated with muscle aerobic capacity.Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.Addison's disease presenting with idiopathic intracranial hypertension in 24-year-old woman: a case report.Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 PatientsValidation of a microscale extraction and high-throughput UHPLC-QTOF-MS analysis method for huperzine A in HuperziaAnabolic signaling deficits underlie amino acid resistance of wasting, aging muscle.Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome.Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists.Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training.Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men.Gene expression responses over 24 h to lengthening and shortening contractions in human muscle: major changes in CSRP3, MUSTN1, SIX1, and FBXO32.Exercise training improves cutaneous microvascular function in nonalcoholic fatty liver disease.The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional studyCirculating pancreatic polypeptide concentrations predict visceral and liver fat content.Evolution in functionality of a metastatic pancreatic neuroendocrine tumour (pNET) causing Cushing's syndrome: treatment response with chemotherapy.GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database.Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality.Rapid Screening of Bovine Milk Oligosaccharides in a Whey Permeate Product and Domestic Animal Milks by Accurate Mass Database and Tandem Mass Spectral Library.Anabolic resistance does not explain sarcopenia in patients with type 2 diabetes mellitus, compared with healthy controls, despite reduced mTOR pathway activity.Utility of metabolomics toward assessing the metabolic basis of quality traits in apple fruit with an emphasis on antioxidantsPeptide receptor radionuclide therapy with (90)Y-DOTATATE/(90)Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicityCompensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)-study protocol.Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes.Hypopituitarism--a late consequence of aneurysmal subarachnoid haemorrhage?Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies.The optimal use of cardiac imaging in the quantification of carcinoid heart disease.Impulse control disorder in a patient on long-term treatment with bromocriptine for a macroprolactinoma.The clinical presentation and management of carcinoid heart disease.Impact of bariatric surgery on physical functioning in obese adults.Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in nonalcoholic fatty liver disease.Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition.Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement.What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle.EffectS of non-nutritive sWeetened beverages on appetITe during aCtive weigHt loss (SWITCH): Protocol for a randomized, controlled trial assessing the effects of non-nutritive sweetened beverages compared to water during a 12-week weight loss periodExercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease.Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study.Exercise training reduces the acute physiological severity of post-menopausal hot flushes.
P50
Q24306423-52E27B84-3BAC-49C9-819D-95865D372094Q30809813-4C7D946D-6028-4CC7-8CE7-C68C61D2F274Q30999856-A9B73852-1D26-4156-830D-7204F182AF54Q33532791-AB575097-D687-4857-ABDA-D6B305F431F6Q33569920-EEC84799-50D3-490F-9AB7-EB2DF680AAF6Q34139654-98455A74-D5FC-4514-B3C3-3CC390D2BBABQ34376051-96C02689-B763-48C2-988D-3F7B894F8E06Q34396898-4C9B8A5A-402C-4BCB-BBC7-3493F5FB9769Q34510307-7B9F3EC9-B8D3-4D98-AD2F-C01002D65BFEQ34547852-F9B44BD1-1F55-4818-B0D2-CD2754F71C8EQ34611635-50BAF5CC-20E4-4333-B11B-65400986C88CQ34629958-7881C2CF-0FE5-437D-91B8-3BF733664D70Q34630868-3E680DB6-CD38-4A9D-9296-C82F180A7895Q34709131-19E3EEA6-CAC4-401C-AEF0-FC96E4F590ABQ34998790-BFAFA049-EA0D-4D8E-BFA6-2A1590FC36BEQ35096854-1A8710E4-3E7D-4E88-8B1F-6788BD8E232AQ35230486-148B2724-3E8B-40D4-859B-E5E714D72149Q35542066-D62617C9-9F85-4E78-A434-65D2D0D08BD9Q35678070-786FF7C2-9D65-467E-92BC-E695310CD1A4Q36080170-5DF344F8-2492-4899-88EF-99929CC1D98DQ36233009-EB199AD4-1BA0-4ED0-9643-7E46BC102404Q36551897-77450722-B7F9-4272-B7A3-58EAC5652EEFQ36775316-2D023695-3471-4D9B-A03A-CFB52500C8F4Q37612158-DF2B2969-BCD4-4B03-B10C-F5CB076FF393Q37777905-1CAB737A-EC4C-4E36-8A16-DBE2777D4AC0Q37847579-93524F96-2009-4BDC-897B-73C86B71E1AFQ38024849-91CEC19B-337F-48CD-BE68-A85337C81970Q38123901-7B1788D5-E1F7-4004-8150-5344F5860521Q38138790-11B51F4B-BB20-40B9-9137-1BCC6F5E38A2Q38196555-E7E7C153-9566-4E42-AFA6-1189E382CA67Q38315029-BC4902D1-4199-41F6-A1E3-C763AF316CBBQ38386409-E5E5A2B2-9242-49A1-9F64-01CB9BA3A9E5Q38592327-E568103E-914D-47E5-9C18-C776FFACC7DFQ38916966-A9F56455-F5E9-4E33-88A7-DA0427FE85B6Q39080491-4E0098DD-782C-4EE7-B702-03B47D99D791Q39094843-799258B7-65A9-462D-8B3B-8B5A8099EB6DQ39097368-598B6F6E-2A11-4C2F-9DEE-F80F48C47986Q39134033-306C3E17-4395-4D60-8ECF-F589BEECCC49Q39176092-5F35C329-F11D-4538-ACE8-5873A6703721Q40203254-01BF4B80-1E26-4649-A925-C5ACF36A6499
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel J Cuthbertson
@es
Daniel J Cuthbertson
@fr
Daniel J Cuthbertson
@sl
Daniel J. Cuthbertson
@en
Daniel J. Cuthbertson
@nl
type
label
Daniel J Cuthbertson
@es
Daniel J Cuthbertson
@fr
Daniel J Cuthbertson
@sl
Daniel J. Cuthbertson
@en
Daniel J. Cuthbertson
@nl
altLabel
Daniel Cuthbertson
@en
prefLabel
Daniel J Cuthbertson
@es
Daniel J Cuthbertson
@fr
Daniel J Cuthbertson
@sl
Daniel J. Cuthbertson
@en
Daniel J. Cuthbertson
@nl
P106
P1153
15032388300
57193540373
P21
P31
P496
0000-0002-6128-0822